Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes

By Villmow T.   Kemkes-Matthes B.   Matzdorff A.C.  

Thrombosis Research, Vol. 108, Iss. 2, 2002-11 ,pp. : 139-145

Elsevier

Access to resources Recommend Favorite

Cilostazol inhibits platelet-leukocyte interaction by suppression of platelet activation

By Ito Hideki   Miyakoda Goro   Mori Toyoki  

Platelets, Vol. 15, Iss. 5, 2004-08 ,pp. : 293-301

Informa Healthcare

Access to resources Recommend Favorite

Combined Thrombolysis with Abciximab Favourably Influences Platelet-Leukocyte Interactions and Platelet Activation in Acute Myocardial Infarction

By Szabo Sebastian   Etzel Diana   Ehlers Raila   Walter Thomas   Kazmaier Silke   Helber Uwe   Hoffmeister Hans  

Journal of Thrombosis and Thrombolysis, Vol. 20, Iss. 3, 2005-12 ,pp. : 155-161

Springer Publishing Company

Access to resources Recommend Favorite

Leukocyte count and leukocyte ecto-nucleotidase are major determinants of the effects of adenosine triphosphate and adenosine diphosphate on platelet aggregation in human blood

By Glenn Jacqueline R.   White Ann E.   Johnson Andrew   Fox Susan C.   Behan Miles W.H.   Dolan Gerry   Heptinstall Stanley  

Platelets, Vol. 16, Iss. 3-4, 2005-06 ,pp. : 159-170

Informa Healthcare

Access to resources Recommend Favorite

The complement factor properdin induces formation of platelet-leukocyte aggregates via leukocyte activation

By Ruef Johannes   Kuehnl Peter   Meinertz Thomas   Merten Michael  

Platelets, Vol. 19, Iss. 5, 2008-08 ,pp. : 359-364

Informa Healthcare

Access to resources Recommend Favorite